Skip to main content
Erschienen in: Annals of Surgical Oncology 13/2011

01.12.2011 | Gynecologic Oncology

Prognostic Value of Pathological Resection Margin Distance in Squamous Cell Cancer of the Vulva

verfasst von: Linn Woelber, MD, Matthias Choschzick, MD, Christine Eulenburg, PhD, Matthaeus Hager, Fritz Jaenicke, MD, Friederike Gieseking, MD, Lilli Kock, MD, Maike Ihnen, MD, Cordula Petersen, MD, Joerg Schwarz, MD, Sven Mahner, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 13/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

A tumor-free resection margin of at least 8 mm is considered state of the art in vulvar cancer. This standard is based on small and heterogeneous patient cohorts, and its implementation can result in mutilation.

Methods

One hundred two consecutive patients with primary squamous cell vulvar cancer were analyzed. All patients received resection of the primary tumor and the inguinofemoral lymph nodes via three separate incisions, resulting in complete tumor resection. Median follow-up was 31 months. Minimal margin distances were pathologically determined in all dimensions after fixation.

Results

Median age of the patients was 62 years; 38.2% had International Federation of Gynecology and Obstetrics (FIGO) stage I, 17.6% stage II, 24.4% stage III, and 8.8% stage IV disease. The median minimal resection margin was 5 mm (range 0.5–25 mm). Sixteen patients (15.6%) developed disease recurrence, of whom 10 (62.5%) at the vulva. Margin distance had no significant impact on disease-free survival when analyzed continuously (p = 0.388). When cases were divided into three subgroups of <3 mm (28.4%), ≥3 to <8 mm (42.2%), and ≥8 mm (29.4%) resection margin, neither univariate nor multivariate analysis revealed a difference in disease-free survival. There was no significant difference between any of the subgroups regarding tumor stages and adjuvant radiotherapy of the vulva. These results were independent of the direction of the minimal margin distance and consistent when only vulvar recurrences were analyzed.

Conclusions

A tumor-free resection margin is essential for locoregional control in vulvar cancer. However, in this large, single-center study, we could not demonstrate any prognostic impact of pathological margin distance.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.PubMedCrossRef Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.PubMedCrossRef
2.
Zurück zum Zitat Judson PL, Habermann EB, Baxter NN, et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107:1018–22.PubMedCrossRef Judson PL, Habermann EB, Baxter NN, et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107:1018–22.PubMedCrossRef
3.
Zurück zum Zitat American, Cancer, Society. Key statistics about vulvar cancer. In Edition 2010. American, Cancer, Society. Key statistics about vulvar cancer. In Edition 2010.
4.
Zurück zum Zitat Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9.PubMedCrossRef Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9.PubMedCrossRef
5.
Zurück zum Zitat Chan JK, Sugiyama V, Pham H, et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol. 2007;104:636–41.PubMedCrossRef Chan JK, Sugiyama V, Pham H, et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol. 2007;104:636–41.PubMedCrossRef
6.
Zurück zum Zitat De Hullu JA, Hollema H, Lolkema S, et al. Vulvar carcinoma. The price of less radical surgery. Cancer. 2002;95:2331–8.PubMedCrossRef De Hullu JA, Hollema H, Lolkema S, et al. Vulvar carcinoma. The price of less radical surgery. Cancer. 2002;95:2331–8.PubMedCrossRef
7.
Zurück zum Zitat de Hullu JA, van der Avoort IA, Oonk MH, van der Zee AG. Management of vulvar cancers. Eur J Surg Oncol. 2006;32:825–31.PubMedCrossRef de Hullu JA, van der Avoort IA, Oonk MH, van der Zee AG. Management of vulvar cancers. Eur J Surg Oncol. 2006;32:825–31.PubMedCrossRef
8.
Zurück zum Zitat Hacker NF, Berek JS, Lagasse LD, et al. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol. 1984;63:155–62.PubMed Hacker NF, Berek JS, Lagasse LD, et al. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol. 1984;63:155–62.PubMed
9.
Zurück zum Zitat Heaps JM, Fu YS, Montz FJ, et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38:309–14.PubMedCrossRef Heaps JM, Fu YS, Montz FJ, et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38:309–14.PubMedCrossRef
10.
Zurück zum Zitat Likes WM, Stegbauer C, Tillmanns T, Pruett J. Correlates of sexual function following vulvar excision. Gynecol Oncol. 2007;105:600–3.PubMedCrossRef Likes WM, Stegbauer C, Tillmanns T, Pruett J. Correlates of sexual function following vulvar excision. Gynecol Oncol. 2007;105:600–3.PubMedCrossRef
11.
Zurück zum Zitat Green MS, Naumann RW, Elliot M, et al. Sexual dysfunction following vulvectomy. Gynecol Oncol. 2000;77:73–7.PubMedCrossRef Green MS, Naumann RW, Elliot M, et al. Sexual dysfunction following vulvectomy. Gynecol Oncol. 2000;77:73–7.PubMedCrossRef
12.
Zurück zum Zitat Hampl M, Deckers-Figiel S, Hampl JA, et al. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol. 2008;109:340–5.PubMedCrossRef Hampl M, Deckers-Figiel S, Hampl JA, et al. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol. 2008;109:340–5.PubMedCrossRef
13.
Zurück zum Zitat Petersen I, Schewe C, Schluns K, et al. Inter-laboratory validation of PCR-based HPV detection in pathology specimens. Virchows Arch. 2007;451:701–16.PubMedCrossRef Petersen I, Schewe C, Schluns K, et al. Inter-laboratory validation of PCR-based HPV detection in pathology specimens. Virchows Arch. 2007;451:701–16.PubMedCrossRef
14.
Zurück zum Zitat Tantipalakorn C, Robertson G, Marsden DE, et al. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol. 2009;113:895–901.PubMed Tantipalakorn C, Robertson G, Marsden DE, et al. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol. 2009;113:895–901.PubMed
15.
Zurück zum Zitat Groenen SM, Timmers PJ, Burger CW. Recurrence rate in vulvar carcinoma in relation to pathological margin distance. Int J Gynecol Cancer. 2010;20:869–73.PubMedCrossRef Groenen SM, Timmers PJ, Burger CW. Recurrence rate in vulvar carcinoma in relation to pathological margin distance. Int J Gynecol Cancer. 2010;20:869–73.PubMedCrossRef
16.
Zurück zum Zitat Hockel M, Dornhofer N. Understanding and preventing local tumour recurrence. Lancet Oncol. 2009;10:645–6.PubMedCrossRef Hockel M, Dornhofer N. Understanding and preventing local tumour recurrence. Lancet Oncol. 2009;10:645–6.PubMedCrossRef
17.
Zurück zum Zitat Hockel M, Schmidt K, Bornmann K, et al. Vulvar field resection: novel approach to the surgical treatment of vulvar cancer based on ontogenetic anatomy. Gynecol Oncol. 2010;119:106–13.PubMedCrossRef Hockel M, Schmidt K, Bornmann K, et al. Vulvar field resection: novel approach to the surgical treatment of vulvar cancer based on ontogenetic anatomy. Gynecol Oncol. 2010;119:106–13.PubMedCrossRef
18.
Zurück zum Zitat Burke TW, Levenback C, Coleman RL, et al. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995;57:215–20.PubMedCrossRef Burke TW, Levenback C, Coleman RL, et al. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995;57:215–20.PubMedCrossRef
19.
Zurück zum Zitat Emerson RE, Koch MO, Daggy JK, Cheng L. Closest distance between tumor and resection margin in radical prostatectomy specimens: lack of prognostic significance. Am J Surg Pathol. 2005;29:225–9.PubMedCrossRef Emerson RE, Koch MO, Daggy JK, Cheng L. Closest distance between tumor and resection margin in radical prostatectomy specimens: lack of prognostic significance. Am J Surg Pathol. 2005;29:225–9.PubMedCrossRef
20.
Zurück zum Zitat Epstein JI, Sauvageot J. Do close but negative margins in radical prostatectomy specimens increase the risk of postoperative progression? J Urol. 1997;157:241–3.PubMedCrossRef Epstein JI, Sauvageot J. Do close but negative margins in radical prostatectomy specimens increase the risk of postoperative progression? J Urol. 1997;157:241–3.PubMedCrossRef
21.
Zurück zum Zitat Carlson GW, Styblo TM, Lyles RH, et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol. 2003;10:108–12.PubMedCrossRef Carlson GW, Styblo TM, Lyles RH, et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol. 2003;10:108–12.PubMedCrossRef
22.
Zurück zum Zitat Minhas S, Kayes O, Hegarty P, et al. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int. 2005;96:1040–3.PubMedCrossRef Minhas S, Kayes O, Hegarty P, et al. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int. 2005;96:1040–3.PubMedCrossRef
23.
Zurück zum Zitat Moore HG, Riedel E, Minsky BD, et al. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol. 2003;10:80–5.PubMedCrossRef Moore HG, Riedel E, Minsky BD, et al. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol. 2003;10:80–5.PubMedCrossRef
24.
Zurück zum Zitat Novais EN, Demiralp B, Alderete J, et al. Do surgical margin and local recurrence influence survival in soft tissue sarcomas? Clin Orthop Relat Res. 2010;468:3003–11. Novais EN, Demiralp B, Alderete J, et al. Do surgical margin and local recurrence influence survival in soft tissue sarcomas? Clin Orthop Relat Res. 2010;468:3003–11.
25.
Zurück zum Zitat Burger MP, Hollema H, Emanuels AG, et al. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995;57:327–34.PubMedCrossRef Burger MP, Hollema H, Emanuels AG, et al. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995;57:327–34.PubMedCrossRef
26.
Zurück zum Zitat Preti M, Ronco G, Ghiringhello B, Micheletti L. Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients. Cancer. 2000;88:1869–76.PubMedCrossRef Preti M, Ronco G, Ghiringhello B, Micheletti L. Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients. Cancer. 2000;88:1869–76.PubMedCrossRef
27.
Zurück zum Zitat Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer. 2000;89:116–22. Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer. 2000;89:116–22.
28.
Zurück zum Zitat Stehman FB, Bundy BN, Ball H, Clarke-Pearson DL. Sites of failure and times to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1996;174:1128–32 (discussion 1132–1123).PubMedCrossRef Stehman FB, Bundy BN, Ball H, Clarke-Pearson DL. Sites of failure and times to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1996;174:1128–32 (discussion 1132–1123).PubMedCrossRef
29.
Zurück zum Zitat DeSimone CP, Crisp MP, Ueland FR, et al. Concordance of gross surgical and final fixed margins in vulvar intraepithelial neoplasia 3 and vulvar cancer. J Reprod Med. 2006;51:617–20.PubMed DeSimone CP, Crisp MP, Ueland FR, et al. Concordance of gross surgical and final fixed margins in vulvar intraepithelial neoplasia 3 and vulvar cancer. J Reprod Med. 2006;51:617–20.PubMed
Metadaten
Titel
Prognostic Value of Pathological Resection Margin Distance in Squamous Cell Cancer of the Vulva
verfasst von
Linn Woelber, MD
Matthias Choschzick, MD
Christine Eulenburg, PhD
Matthaeus Hager
Fritz Jaenicke, MD
Friederike Gieseking, MD
Lilli Kock, MD
Maike Ihnen, MD
Cordula Petersen, MD
Joerg Schwarz, MD
Sven Mahner, MD
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 13/2011
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1778-0

Weitere Artikel der Ausgabe 13/2011

Annals of Surgical Oncology 13/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.